IGF2 and neoplasm: Several gene alterations in predisposing loci have been well-identified, including mutations in Wilms' tumor gene 1 (WT1), catenin beta 1 (CTNNB1), insulin-like growth factor-2 (IGF2) and Wilms' tumor gene on the X chromosome (WTX) (7–9).